Ledger.Open graph →
SEC Form D · Amendment · filed August 10, 2015

Tocagen Inc

Offering
$39.9M
Sold
$28.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Harry Gruber · San Diego, CAExec · DirectorThomas Darcy · San Diego, CAExec · DirectorFaheem M. Hasnain · San Diego, CADirectorDouglas Jolly · San Diego, CAExecDavid R. Parkinson · San Diego, CADirectorPaul R. Schimmel · San Diego, CADirectorFranklin M. Berger · San Diego, CADirectorDennis Berman · San Diego, CAExec · DirectorMaxwell E. A · Maitland, FLExecVictory Road Investors, LLC · North Quincy, MADirectorMichael A. Okaty · Orlando, FLDirectorMorey H. Goldberg · Wynnewood, PADirectorRick H. Walsh · Orlando, FLExec · DirectorTerry Girling · Nassau, C5DirectorRenato A. Mazzolini · Nassau, C5Exec · DirectorBarry Lieberman · Santa Barbara, CAExec · DirectorEli Aizenstat · Santa Barbara, CAExec · DirectorDavid J. Blumberg · San Francisco, CADirectorMark A. Allen · Cambridge, MADirectorJenny Abramson · White Plains, NYExec · DirectorChristopher A. Mccain · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗